Literature DB >> 6338171

Diagnosis of upper-abdominal infections by In-111 labeled leukocytes with Tc-99m colloid subtraction technique.

M H Rövekamp, E A van Royen, S C Folmer, J B van der Schoot.   

Abstract

In 65 patients suspected of upper-abdominal inflammatory disease, indium-111 leukocyte scintigraphy was combined with a Tc-99m(Sn)colloid scan by computer-assisted subtraction. In 84% of these cases, a definite diagnosis would not have been possible without this method of subtraction. Accuracy was found to be 80%, sensitivity 93%, and specificity 59%. False-positive results were due either to noninfectious inflammatory lesions with accumulation of leukocytes or to some pitfalls in the subtraction technique itself.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6338171

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  5 in total

Review 1.  Imaging intraabdominal abscesses and nonoperative drainage procedures.

Authors:  J R Haaga
Journal:  World J Surg       Date:  1990 Mar-Apr       Impact factor: 3.352

2.  Indium 111 leucocyte scintigraphy in abdominal sepsis. Do the results affect management?

Authors:  A A Baba; J H McKillop; G F Cuthbert; W Neilson; H W Gray; J R Anderson
Journal:  Eur J Nucl Med       Date:  1990

3.  Indium leucocyte imaging in true pyrexia of unknown origin.

Authors:  R J Hawker; C E Hall; Z Drolc; P H Rhys-Evans
Journal:  Eur J Nucl Med       Date:  1985

4.  Limitations in the use of indium-111-oxine-labeled leucocytes for the diagnosis of occult infection in children.

Authors:  M Haentjens; A Piepsz; E Schell-Frederick; N Perlmutter-Cremer; J Frühling
Journal:  Pediatr Radiol       Date:  1987

5.  Comparison of 99m technetium hexamethylpropylene-amine oxime labelled leucocyte with 111-indium tropolonate labelled granulocyte scanning and ultrasound in the diagnosis of intra-abdominal abscess.

Authors:  M J Weldon; A E Joseph; A French; S H Saverymuttu; J D Maxwell
Journal:  Gut       Date:  1995-10       Impact factor: 23.059

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.